Biocept

BIOC NASDAQ
0.9177
+0.0002
+0.02%
Opening 12:41 08/19 EDT
Open
0.9500
Prev Close
0.9175
High
0.9500
Low
0.9175
Volume
217.25K
Avg Vol (3M)
3.64M
52 Week High
3.880
52 Week Low
0.6580
% Turnover
0.94%
Market Cap
21.12M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Biocept BIOC stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Biocept, Inc. is an early commercial-stage molecular oncology diagnostics company. The Company develops and commercializes circulating tumor cell (CTC) and circulating tumor deoxyribonucleic acid (ctDNA), assays utilizing a standard blood sample, or liquid biopsy. The Company's Target-Selector offering is based on an internally developed, microfluidics-based CTC capture and analysis platform, with enabling features that change how CTC testing can be used by clinicians by providing biomarker detection and monitoring requiring only a standard blood sample. The ctDNA technology enables mutation detection and is applicable to nucleic acid from CTCs or other sample types, such as blood plasma. The Company commercializes its Target-Selector assays for a range of solid tumor indications, such as breast cancer, non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), gastric cancer, colorectal cancer, prostate cancer and melanoma.
MORE >

Recently

Name
Price
%Change